Xuantai Pharmaceutical: The approval number of Clorazepate Dipotassium Sustained-Release Tablets by INVIMA in Colombia.

Xuantai Pharmaceuticals announced on May 25th that the company has received a notification from the National Drug and Food Supervision and Administration of Colombia that the company's application for the generic drug of slow-release tramadol hydrochloride has been officially approved. The main ingredient of slow-release tramadol hydrochloride is tramadol hydrochloride, which belongs to the class of amino ketone antidepressants. The approved indications for this drug are the treatment of severe depression and the prevention of seasonal affective disorder.